EDVA (Endovia Health Sciences) Short-Term Debt: $6.39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EDVA Endovia Health Sciences Inc EDVA
20 GF Score
Price $0.39
! 9 Warning Signs
View Full Analysis

What is Endovia Health Sciences Short-Term Debt?

Endovia Health Sciences EDVA +3.56% 20 Short-Term Debt is $6.39 Mil as of Jun. 2026. GuruFocus rates EDVA with a GF Score™ of 20/100. The stock has 9 warning signs investors should review.

Endovia Health Sciences's Short-Term Debt for the quarter that ended in Jun. 2026 was $6.39 Mil.

Endovia Health Sciences's quarterly Short-Term Debt declined from Dec. 2025 ($6.62 Mil) to Mar. 2026 ($6.31 Mil) but then increased from Mar. 2026 ($6.31 Mil) to Jun. 2026 ($6.39 Mil).

Endovia Health Sciences's annual Short-Term Debt increased from Dec. 2023 ($8.33 Mil) to Dec. 2024 ($10.22 Mil) but then declined from Dec. 2024 ($10.22 Mil) to Dec. 2025 ($6.62 Mil).

Endovia Health Sciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Endovia Health Sciences Short-Term Debt Related Terms

Endovia Health Sciences Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Endovia Health Sciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endovia Health Sciences Short-Term Debt Chart

Endovia Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.71 1.08 8.33 10.22 6.62

Endovia Health Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 6.22 6.62 6.31 6.39
EDVA
20GF Score
Endovia Health Sciences Inc EDVA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $6.39 Mil mean?
Endovia Health Sciences (EDVA) has a Short-Term Debt of $6.39 Mil as of Jun. 2026.
Is Endovia Health Sciences' Short-Term Debt too high?
Endovia Health Sciences' current Short-Term Debt is $6.39 Mil. Overall, Endovia Health Sciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Endovia Health Sciences' Short-Term Debt compare to YHC and IBG?
Endovia Health Sciences' Short-Term Debt of $6.39 Mil can be compared against companies in the Beverages - Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Beverages - Alcoholic company?
A good Short-Term Debt depends on the Beverages - Alcoholic industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Endovia Health Sciences's current Short-Term Debt is $6.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endovia Health Sciences stock overvalued right now?
Endovia Health Sciences (EDVA) has a current Short-Term Debt of $6.39 Mil. The current Short-Term Debt is $6.39 Mil. Endovia Health Sciences' overall GF Score™ is 20/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Endovia Health Sciences (EDVA), the current Short-Term Debt is $6.39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endovia Health Sciences Business Description

Address 1314 East Las Olas Boulevard, Suite 221, Fort Lauderdale, FL, USA, 33301
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce.
20GF Score

Get the complete analysis for EDVA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price